InsidersTradesSigma
Synsam AB (publ): management transactions · Finland · FIN-FSA
FI:synsam-ab-publSE0016829709FI·FIN-FSAMcap 7.4Bn€Healthcare & Pharma
Browse the full directors' dealings record of Synsam AB (publ), a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare & Pharma sector, Synsam AB (publ) has published 17 insider filings. Market capitalisation: €7.4bn. The latest transaction was reported on 13 May 2026 — Purchase. Among the most active insiders: Håkan Lundstedt. Every trade is free.
17
Insider Decl.
0
Thresholds
€601,608
17 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
52.30 €
Analyst consensus
3 analystsStrong buy
75.00 €Target 79.00 €(+51%)82.00 €
Valuation
PER (trailing)15.1x
PER (forward)11.4x
P/Book2.9x
Balance sheet & cash
Market cap7.42 Bn€
Debt / Equity139%
Profitability & ownership
ROE19.6%
ROA6.6%
% insiders24.4%
% institutions60.3%
Last declaration on 13 May 2026
Declarations17 total
Executives●Purchase16FIN-FSA
SEK 72,57815,200 shares@ SEK 4.77490.0010% mcap100.0% of flow
Aktie
FI:A003Y531-1·
Ideal exit: 6 Feb 2027 (T+270)
Executives●Purchase20FIN-FSA
€18,6073,058 shares@ €6.08460.0003% mcap100.0% of flow
Aktie
FI:A003W750-1·
Ideal exit: 29 Nov 2026 (T+270)
Executives●Purchase24FIN-FSA
€23,7433,909 shares@ €6.07390.0003% mcap83.7% of flow
Aktie
FI:A003U622-1·
Ideal exit: 8 Sept 2026 (T+270)
Executives●Purchase29FIN-FSA
€45,1777,520 shares@ €6.00760.0006% mcap15.2% of flow
Aktie
FI:A003U532-1·
Ideal exit: 4 Sept 2026 (T+270)
Executives●Purchase15FIN-FSA
€3,251627 shares@ €5.18460.0000% mcap27.4% of flow
Aktie
FI:A003S119-1·
Ideal exit: 5 Jun 2026 (T+270)
Executives●Purchase29FIN-FSA
€50,21410,000 shares@ €5.02140.0007% mcap16.9% of flow
Aktie
FI:A003R749-1·
Ideal exit: 23 May 2026 (T+270)
Executives●Purchase16FIN-FSA
€36,0148,000 shares@ €4.50170.0005% mcap41.7% of flow
Aktie
FI:A003O686-3·
Ideal exit: 13 Feb 2026 (T+270)
Executives●Purchase18FIN-FSA
€50,26412,000 shares@ €4.18870.0007% mcap58.3% of flow
Aktie
FI:A003P631-3·
Ideal exit: 8 Mar 2026 (T+270)
Executives●Purchase29FIN-FSA
€49,23210,000 shares@ €4.92320.0007% mcap16.5% of flow
Aktie
FI:A003Q511-1·
Ideal exit: 4 Apr 2026 (T+270)
Executives●Purchase16FIN-FSA
€50,26412,000 shares@ €4.18870.0007% mcap36.7% of flow
Aktie
FI:A003P633-1·
Ideal exit: 8 Mar 2026 (T+270)
Executives●Purchase28FIN-FSA
€35,7848,164 shares@ €4.38320.0005% mcap12.0% of flow
Aktie
FI:A003O733-1·
Ideal exit: 13 Feb 2026 (T+270)
Executives●Purchase18FIN-FSA
€86,75919,500 shares@ €4.44920.0012% mcap63.3% of flow
Aktie
FI:A003O688-1·
Ideal exit: 13 Feb 2026 (T+270)
Executives●Purchase29FIN-FSA
€44,93811,700 shares@ €3.84080.0006% mcap15.1% of flow
Aktie
FI:A003N345-1·
Ideal exit: 6 Jan 2026 (T+270)
Executives●Purchase32FIN-FSA
€7,9582,000 shares@ €3.97890.0001% mcap100.0% of flow
Aktie
FI:A003M438-1·
Ideal exit: 7 Dec 2025 (T+270)
Executives●Purchase18FIN-FSA
€4,6231,150 shares@ €4.02010.0001% mcap16.3% of flow
Aktie
FI:A003M491-1·
Ideal exit: 7 Dec 2025 (T+270)
Executives●Purchase24FIN-FSA
€13,5893,360 shares@ €4.04440.0002% mcap100.0% of flow
Aktie
FI:A003M474-1·
Ideal exit: 7 Dec 2025 (T+270)
Executives●Purchase23FIN-FSA
€8,6142,170 shares@ €3.96980.0001% mcap72.6% of flow
Aktie
FI:A003M445-1·
Ideal exit: 7 Dec 2025 (T+270)
17 of 17 declarations
